Technological Innovation and Women’s Leadership in Biotechnology: A Study of Dr. Gagandeep Kang’s Research Impact
As of 2026, Dr. Gagandeep Kang is a preeminent figure in global biotechnology, widely recognized as India's " Vaccine Godmother ". Her leadership has fundamentally reshaped vaccine development and public health policy, particularly through her work on enteric diseases and indigenous vaccine innovation. Technological Innovation & Research Impact Dr. Kang's research centers on the epidemiology and immunology of viral infections in children. Rotavirus Vaccine (Rotavac) : She served as one of three principal investigators in the Phase III clinical trials for Rotavac, India's first indigenously developed rotavirus vaccine. This was a landmark public-private partnership with Bharat Biotech that produced an affordable vaccine tailored to local needs, potentially saving hundreds of thousands of lives annually. Surveillance & Methodology: She established the largest single birth cohort study on rotaviral infections globally, proving that vaccine efficacy in deve...